Heartache of Fc Receptors**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Journal of the American College of Cardiology

Volumn 49, Issue 16, 2007, Pages 1693-1695

  Gupta, Sudhir ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD32 ANTIGEN; DEATH RECEPTOR; FC RECEPTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; TROPONIN I;

CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY DISEASE; EDITORIAL; HEART TRANSPLANTATION; HUMAN; IMMUNOADSORPTION; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR AFFINITY;

ANIMALS; AUTOANTIBODIES; CARDIOMYOPATHY, DILATED; HUMANS; IMMUNOGLOBULIN G; MICE; RECEPTORS, FC;

EID: 34247109502     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.02.018     Document Type: Editorial

References (17)

1. Okazaki T., and Honjo T. Pathogenic roles of cardiac autoantibodies in dilated cardiomyopathy. Trends Mol Med 11 (2005) 322-326
2. Okazaki T., Tanaka Y., Nishio R., et al. Autoantibodies against cardiac troponin I are responsible for dilated cardiomypathy in PD-1-deficient mice. Nat Med 9 (2003) 1477-1483
3. Shmilovich H., Danon A., Binah O., et al. Autoantibodies to cardiac troponin I in patients with idiopathic dilated and ischemic cardiomyopathy. Int J Cardiol 117 (2007) 198-203
4. Jahns R., Boivin V., and Lohse M.J. β1-adrenergic receptor function, autoimmunity, and pathogenesis of dilated cardiomypathy. Trends Cardiovasc Med 16 (2006) 20-24
5. Felix S.B., Staudt A., Landsberger M., et al. Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption. J Am Coll Cardiol 39 (2002) 646-652
6. Muller J., Wallukat G., Dandel M., et al. Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation 101 (2000) 385-391
7. Chen J., Larrson L., Haugen E., et al. Effect of autoantibodies removal by immnoadsorption from patients with dilated cardiomyopathy on neonatal rat cardiomyocytes. Eur J Immunol 8 (2006) 460-467
8. Gupta S. Molecular mechanisms of apoptosis in the cells of the immune system in human aging. Immunol Rev 205 (2005) 114-129
9. Orrenius S., Zhivotovski B., and Nicotera P. Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol 4 (2003) 552-556
10. γ receptors IIa on cardiomyocytes and their potential functional relevance in dilated cardiomyopathy. J Am Coll Cardiol 49 (2007) 1684-1692
11. Takai T. Role of Fc receptors in autoimmunity. Nat Rev Immunol 2 (2002) 580-592
12. Nimmerjahn F., and Ravetch J.V. Fcγ receptors: old friends and new family members. Immunity 24 (2005) 19-28
13. Staudt A., Bohm M., Knebel F., et al. Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients suffering from dilated cardiomypathy. Circulation 106 (2002) 2448-2453
14. McNamara D.M., Rosenblum W.D., Janosko K.M., et al. Intravenous immune globulin therapy of myocarditis and acute cardiomyopathy. Circulation 95 (1997) 2476-2478
15. Larsson L., Reza M., Pal A., et al. Beneficial effect on cardiac function by intravenous immunoglobulin treatment in patients with dilated cardiomyopathy is not due to neutralization of anti-receptor autoantibodies. Autoimmunity 37 (2004) 489-493
16. Gullestad L., Aass H., Fjeld J.G., et al. Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure. Circulation 103 (2001) 220-225
17. Omerovic E., Bollano E., Andersson B., et al. Induction of cardiomyopathy in severe combined immunodeficiency mice by transfer of lymphocytes from patients with dilated cardiomyopathy. Autoimmunity 32 (2000) 271-280